Perspectives on Latest Therapies: Faricimab and Aflibercept 8mg

Dr. London discusses the implications of faricimab and aflibercept 8 mg in treating retinal diseases, highlighting their mechanisms, efficacy data, and potential to enhance patient outcomes in conditions like wet age-related macular degeneration.

EP: 1.A case of longstanding bilateral neovascular AMD

Now Viewing

EP: 2.Perspectives on Latest Therapies: Faricimab and Aflibercept 8mg

Recent Videos